QXO (QXO) had the highest return between October 1, 2011 and November 30, 2012 by a US stock with a market cap of $2B+, returning 4,704,125%.
| ASSET | DATE | % RETURN |
|---|---|---|
QXO (QXO) | 10/1/2011 - 11/30/2012 | 4,704,125% |
Par Pacific (PARR) | 10/1/2011 - 11/30/2012 | 1,800% |
Patrick Industries (PATK) | 10/1/2011 - 11/30/2012 | 839.56% |
ACADIA Pharmaceuticals (ACAD) | 10/1/2011 - 11/30/2012 | 385.98% |
Sarepta Therapeutics (SRPT) | 10/1/2011 - 11/30/2012 | 344.39% |
PulteGroup (PHM) | 10/1/2011 - 11/30/2012 | 331.03% |
Builders FirstSource (BLDR) | 10/1/2011 - 11/30/2012 | 312.7% |
M/I Homes (MHO) | 10/1/2011 - 11/30/2012 | 269.3% |
HCI (HCI) | 10/1/2011 - 11/30/2012 | 247.92% |
PDF Solutions (PDFS) | 10/1/2011 - 11/30/2012 | 246.13% |
Louisiana-Pacific (LPX) | 10/1/2011 - 11/30/2012 | 243.59% |
Cheniere Energy (LNG) | 10/1/2011 - 11/30/2012 | 234% |
Eagle Materials (EXP) | 10/1/2011 - 11/30/2012 | 228.33% |
Stewart Information Services (STC) | 10/1/2011 - 11/30/2012 | 212.72% |
Regeneron Pharmaceuticals (REGN) | 10/1/2011 - 11/30/2012 | 207.74% |
Lennar (LEN.B) | 10/1/2011 - 11/30/2012 | 201.74% |
Cemex SAB de CV ADR (CX) | 10/1/2011 - 11/30/2012 | 194.79% |
Lennar (LEN) | 10/1/2011 - 11/30/2012 | 186.06% |
NeoGenomics (NEO) | 10/1/2011 - 11/30/2012 | 170.46% |
LyondellBasell Industries (LYB) | 10/1/2011 - 11/30/2012 | 162.5% |
Celldex Therapeutics (CLDX) | 10/1/2011 - 11/30/2012 | 161.67% |
Alnylam Pharmaceuticals (ALNY) | 10/1/2011 - 11/30/2012 | 161.08% |
Expedia (EXPE) | 10/1/2011 - 11/30/2012 | 160.04% |
DXP Enterprises (DXPE) | 10/1/2011 - 11/30/2012 | 159.21% |
Seagate Technology (STX) | 10/1/2011 - 11/30/2012 | 158.15% |